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The Right to Health and the Nevirapine Case in South Africa
George J. Annas, J.D., M.P.H.
Thanks to activists in South Africa, the right to health
as a human right has returned to the international
stage, just as it was being displaced by economists
who see health through the prism of a globalized
economy and by politicians who see it as an issue
of national security or charity. The current post-apartheid debate in South Africa is not about race but
about health, and in this context, the court victory
by AIDS activists in the nevirapine case has been
termed not only, as stated in one British newspaper,
“the greatest defeat for [President Thabo] Mbeki’s
government” but also the opening of “legitimate
criticism” of the government “over a host of issues
from land rights to the pursuit of wealth.”1 Using
the nevirapine case as a centerpiece, I will explore
the power of the human right to health in improving health generally.
Jonathan Mann rightly observed that “health
and human rights are inextricably linked,”2 and
Paul Farmer has argued that “the most important
question facing modern medicine involves human rights.”3 Farmer noted that many poor people have no access to modern medicine and concluded, “The more effective the treatment, the
greater the injustice meted out to those who do
not have access to care.”3 Access to treatment for
infection with the human immunodeficiency virus (HIV) and AIDS has been problematic in most
countries, but especially in South Africa, where
almost 5 million people are infected with HIV and
the government’s attitude toward the epidemic
has been described as pseudoscientific and dangerous.4 Political resistance by the South African
government to outside funders who want to set
the country’s health care agenda is, of course, understandable in the context of racism and colonialism.5 But even understandable politics cannot excuse the government’s failure to act more
decisively in the face of an unprecedented epidemic.

750

n engl j med 348;8

hiv infection
and the right to health
One of the most controversial actions of the South
African government was its restriction of the use
of nevirapine to prevent the transmission of HIV
from mothers to infants. Only two government hospitals per province were allowed to use the drug. The
Treatment Action Campaign was formed in 1998
as a coalition of South African AIDS-related organizations to promote affordable treatment for all people with HIV infection or AIDS. This group (and
others) scored a victory in 2001, when 39 multinational pharmaceutical companies withdrew their
lawsuit against the South African government, which
sought to enforce their patents on drugs for the
treatment of HIV infection or AIDS, in order to prevent the government from purchasing generic versions of the drugs.6
At about the same time, the Treatment Action
Campaign brought a suit against the South African
government itself, alleging that its restrictions on
the availability of nevirapine (limiting it in the public sector to hospitals involved in a pilot study) and
its failure to have a reasonable plan to make the
drug more widely available violated the right to
health of HIV-positive pregnant women and their
children guaranteed in the South African constitution. The use of nevirapine remains controversial
in Africa, even after a study in Uganda, published
in 1999, suggested that administering the drug to a
pregnant woman at the onset of labor and to her
newborn immediately after birth could result in a
50 percent reduction in the rate of transmission of
HIV.7 This is the basis for the claim that failure to
use nevirapine condemns 35,000 newborns a year
to HIV infection in South Africa.1
The Treatment Action Campaign prevailed in
the trial court, which ruled that restricting nevirapine to a limited number of pilot sites in the public
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sector “is not reasonable and is an unjustifiable barrier to the progressive realization of the right to
health care.”8 In July 2002, the Constitutional Court
of South Africa, the country’s highest court, affirmed
the ruling, stating that the government’s nevirapine
policy violated the health care rights of women and
newborns under the South African constitution.9
Section 27 of the post-apartheid constitution states,
“(1) Everyone has the right to have access to
(a) health care services, including reproductive
health care; (b) sufficient food and water; and (c) social security. . . . (2) The state must take reasonable legislative and other measures, within its available resources, to achieve the progressive realization
of each of these rights. (3) No one may be refused
emergency medical treatment.” Section 28 states,
“(1) Every child has a right . . . (b) to family care
or parental care, or to appropriate alternative care
when removed from the family environment; (c) to
basic nutrition, shelter, basic health care services
and social services. . . . (2) A child’s best interests
are of paramount importance in every matter concerning the child.”9
These rights are part of the bill of rights in the
South African constitution, which the constitution
itself requires the state to “respect, protect, promote
and fulfill.” These provisions are modeled on those
in the International Covenant on Economic, Social
and Cultural Rights (which has been signed, but
not yet ratified, by South Africa).10 Under the covenant, the right to health includes not only appropriate health care, but also the underlying determinants of health, including clean water, adequate
sanitation, safe food and housing, and health-related education.11 South Africa’s constitutional health
obligations apply to every branch of government.
The Constitutional Court considered two questions:
what actions the government was constitutionally
required to take with regard to nevirapine, and
whether the government had an obligation to establish a comprehensive plan for the prevention of
HIV transmission from mother to child.

making nevirapine available
As justification for its refusal to make nevirapine
generally available in public clinics, the South African government has argued that the drug’s safety
and efficacy have not been satisfactorily established
and that it is of limited benefit in a breast-feeding
population (since the number of infants acquiring
HIV from breast-feeding would be almost as large
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as the number infected in the absence of preventive
treatment with nevirapine). These views have been
articulated by the minister of health, who along with
President Mbeki, continues to take positions on HIV
infection and its treatment that scientists in the
rest of the world find baffling.4,5
In January 2001, after a meeting of southern African countries, the World Health Organization recommended the administration of nevirapine to
HIV-positive women who are pregnant and to their
children at the time of birth. In April 2001, the Medicines Control Council, South Africa’s equivalent of
the Food and Drug Administration, formally approved nevirapine as safe and effective. Shortly
thereafter, in July 2001, the government decided to
do the pilot study of nevirapine that was at issue in
the lawsuit; this study limited the drug’s availability
to two sites in each province. The result was that
physicians who worked at other facilities in the public sector were unable to prescribe this drug for their
patients, even though the manufacturer of the drug,
Boehringer Ingelheim, had agreed to make it available at no cost for a five-year period.
The Treatment Action Campaign argued that in
the face of the HIV epidemic, which includes the infection of approximately 70,000 infants from their
mothers annually, it was irrational and a breach of
the bill of rights for the government to prohibit physicians in public clinics from prescribing nevirapine
for preventive purposes when medically indicated.9

enforcing the obligation
to respect rights
This was the third case in which the Constitutional
Court had been asked to enforce a socioeconomic
right under the South African constitution. The first,
Soobramoney v. Minister of Health, was also a right-tohealth case.12 It involved a 41-year-old man with
chronic renal failure and a history of stroke, heart
disease, and diabetes, who was not eligible for a
kidney transplant and therefore required lifelong
dialysis to survive. The renal-dialysis unit in the region where he lived, which had 20 dialysis machines
— not nearly enough to provide dialysis for everyone who required it — had a policy of accepting
only patients with acute renal failure. The health department argued that this policy met the government’s duty to provide emergency care under the
constitution. Patients with chronic renal failure, like
the petitioner, did not automatically qualify.
In considering whether the constitution required
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the health department to provide a sufficient number of machines to offer dialysis to everyone whose
life could be saved by it, the court observed that under the constitution, the state’s obligation to provide health care services was qualified by its “available resources.” The court noted that offering
extremely expensive medical treatments to everyone would make “substantial inroads into the
health budget . . . to the prejudice of the other
needs which the state has to meet.”12 The Constitutional Court ultimately decided that the administrators of provincial health services, not the courts,
should set budgetary priorities and that the courts
should not interfere with decisions that are rational
and made “in good faith by the political organs and
medical authorities whose responsibility it is to
deal with such matters.”12
Likewise, in South Africa v. Grootboom, a case involving the right to housing, the Constitutional
Court determined that although the state is obligated to act positively to ameliorate the conditions of
the homeless, it “is not obligated to go beyond available resources or to realize these rights immediately.”13 The constitutional requirement is that the
right to housing be “progressively realized.” Nonetheless, the court noted, there is “at the very least,
a negative obligation placed upon the state and all
other entities and persons to desist from preventing or impairing the right of access to adequate
housing.”13,14
Applying the rulings in these two cases to the
nevirapine case, the Constitutional Court reasonably concluded that the right to health care services
“does not give rise to a self-standing and independent fulfillment right” that is enforceable irrespective of available resources. Nonetheless, the government’s obligation to respect rights, as articulated in
the housing case, applies equally to the right to
health care services.9

enforcing the obligation
to protect rights
The Constitutional Court reframed the two questions it would answer in the light of the South African government’s obligation to take “reasonable
steps” for the “progressive realization” of the right
to health as follows: “Is the policy of confining the
supply of nevirapine reasonable in the circumstances; and does the government have a comprehensive policy for the prevention of mother-to-child
transmission of HIV?”9
The South African government argued that the
752
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real cost of delivering nevirapine is not the cost of
the drug but the cost of the infrastructure of care:
HIV testing, counseling, follow-up, and the provision of formula for parents who cannot currently
afford it. The Constitutional Court agreed that the
ideal is to make these preventive services universally available but restated the dispute as “whether it
was reasonable to exclude the use of nevirapine for
the treatment of mother-to-child transmission at
those public hospitals and clinics where testing and
counseling are available.”9
The South African government gave four reasons
for its restriction of the use of nevirapine: its efficacy would be diminished in settings in which a comprehensive package of services, including breastmilk substitutes, was not available; administration
of the drug might produce a drug-resistant form of
HIV; the safety of nevirapine has not been adequately demonstrated; and the public health system does
not have the capacity to deliver the “full package”
of services.9
The court addressed each point in turn. With respect to efficacy, the court found that breast-feeding does increase the risk of HIV infection “in some,
but not all cases and that nevirapine thus remains
to some extent efficacious . . . even if the mother
breastfeeds her baby.”9 The court conceded that
drug resistance is possible but concluded, “The
prospects of the child surviving if infected are so
slim and the nature of the suffering [is] so grave that
the risk of some resistance manifesting at some
time in the future is well worth running.”9 The safety issue was disposed of by reference to the World
Health Organization’s recommendation of nevirapine and the determination of the Medicines
Control Council that the drug is safe. As for capacity, the court concluded that resources are relevant
to the universal delivery of the “full package” but
are “not relevant to the question of whether nevirapine should be used to reduce mother-to-child
transmission of HIV at those public hospitals and
clinics outside the research sites where facilities in
fact exist for testing and counseling.”9

the rights of children and the
obligation to fulfill rights
This case is a right-to-health case because it concerns the availability of a drug and the circumstances under which the government can reasonably restrict its use. Nonetheless, the case could have been
decided solely on the basis of the rights of children. In the words of the Constitutional Court, “This
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case is concerned with newborn babies whose lives
might be saved by the administration of nevirapine to mother and child at the time of birth.”9 The
court specifically cites the constitutional rights of
children, including their right to “basic health care
services.” Parents have the primary obligation to
provide these services to children but often cannot
meet this obligation without help from the state.15
The court concluded that nevirapine is an “essential” drug for children whose mothers are infected
with HIV, that the needs of these children are “most
urgent,” and that their ability to exercise all other
rights is “most in peril.”9 The court did not write
about the certainty of the children becoming orphans if their mothers do not also have access to
treatment, but treatment of HIV infection and AIDS
was beyond the scope of this case, which concerned
the prevention of HIV infection.
On the basis of either the right to health or the
rights of children, the court’s answer to the first
question was that the policy of restricting the availability of nevirapine is unreasonable and a violation
of the government’s obligation to take “reasonable
legislative and other measures, within its available
resources, to achieve the progressive realization” of
the right to “access to health care services, including reproductive health care.”9 In the court’s words,
“A potentially lifesaving drug was on offer and where
testing and counseling facilities were available it
could have been administered within the available
resources of the state without any known harm to
mother and child.”9 The question of whether the
cost of nevirapine mattered was not addressed, although the outcome almost certainly would have
been different had nevirapine not been available at
no or very low cost.
The answer to the second question — whether
the government is required to have a reasonable,
comprehensive plan to combat mother-to-child
transmission of HIV — flowed directly from the
answer to the first. The legal question was whether
the government’s plan of moving slowly from limited research and training programs to more available programs was reasonable. The court decided
that because of the “incomprehensible calamity” of
the HIV epidemic in South Africa, the government’s
plan was not reasonable.

the right to the progressive
realization of health

department in deciding how money should be spent
on health care? The court did not think so, pointing
out that all branches of the government have the
obligation to “respect, protect, promote and fulfill”
the socioeconomic rights spelled out in the constitution. The legislative branch is obligated to pass
“reasonable legislative” measures, and the executive
branch is obligated to develop and implement “appropriate, well-directed policies and programs.”9 It
is, of course, the role of the judiciary to resolve disputes about whether a specific law or policy, or its
implementation, is consistent with the terms of
the constitution. Since the initiation of the nevirapine lawsuit, three of the country’s nine provinces
— Western Cape, Gauteng, and KwaZulu-Natal
— have publicly announced a plan to realize progressively “the rights of pregnant women and their
newborn babies to have access to nevirapine.”9 The
court expects the other six provinces to follow suit.
The court was explicit both in defining the rights
that were violated and in ordering a remedy. As to
the rights, the court declared that “Sections 27(1)
and (2) of the Constitution require the government
to devise and implement within its available resources a comprehensive and coordinated program to
realize progressively the rights of pregnant women
and their newborn children to have access to health
services to combat mother-to-child transmission of
HIV.”9 To implement this right, the court ordered
the government to take four specific actions:
Remove the restrictions that prevent nevirapine from being made available . . . at public hospitals and clinics that are not research
and training sites.
Permit and facilitate the use of nevirapine
. . . at public hospitals and clinics when
. . . this is medically indicated. . . .
Make provision if necessary for counselors
based at public hospitals and clinics . . . to
be trained for counseling. . . .
Take reasonable measures to extend the testing and counseling facilities at hospitals and
clinics throughout the public health sector to
facilitate and expedite the use of nevirapine.9

implementing the right to health

Can the Constitutional Court be accused of taking The decision in the nevirapine case illustrates both
on the role of the South African government’s health the strength and the weakness of relying on courts
n engl j med 348;8
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to determine specific applications of the right to
health. The strength is that the right to health is a
legal right, and since there can be no legal right
without a remedy, courts will provide a remedy for
violations of the right to health. In this regard, it
is worth noting not only that the right to health
and access to health care articulated in the Universal Declaration of Human Rights has been given
more specific meaning in the International Covenant on Economic, Social and Cultural Rights10,11
and other internationally binding documents on
human rights, but also that these rights have been
written into the constitutions of many countries,
including South Africa. The widespread failure of
governments to take the right to health seriously,
however, means that we are still a long way from the
realization of this right. Nonetheless, the recent activism of many new nongovernmental organizations, such as the Treatment Action Campaign, in
the area of health rights, provides some ground for
optimism that government inaction will not go unchallenged.16
The weakness of relying on courts is that the
subject matter of the right to health in a courtroom
struggle is likely to be narrow, involving interventions such as kidney dialysis or nevirapine therapy.
The HIV epidemic demands a comprehensive strategy of treatment, care, and prevention, including
education, adequate nutrition, clean water, and nondiscrimination.2,11,17 The government of South Africa has so far been unwilling to designate the HIV
epidemic as a national emergency or to take steps
to make the prevention and treatment of HIV infection its highest health priority. This stance has
apparently changed little since the decision on nevirapine was handed down. The South African government, for example, has asked the Medicines
Control Council to review its approval of nevirapine
because of continued doubt about its safety and efficacy.18 Of course, if the council withdraws its approval of the drug, this action will effectively render
the Constitutional Court’s decision moot, since its
orders are based on the finding that nevirapine is
safe and effective. On the more positive side, South
Africa’s cabinet has announced that it is considering
universal access to antiretroviral drugs, and Ranbaxy, the largest manufacturer of generic drugs in
India, has formed a joint venture with Adcock Ingram
to distribute generic antiretroviral agents in South
Africa.19
Former South African president Nelson Mandela has persuasively argued that an effective strat-
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egy for combatting the AIDS epidemic requires the
engaged commitment of national leaders to provide
not only prevention but also treatment for everyone
who needs it, “wherever they may be in the world
and regardless of whether they can afford to pay or
not.”20 Lack of leadership in addressing the HIV
epidemic specifically and the right to health in general is not, of course, confined to South Africa.
From the Health Law Department, Boston University School of
Public Health, Boston.
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